Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers.

Soltani A, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH.

PLoS One. 2012;7(6):e39736. doi: 10.1371/journal.pone.0039736. Epub 2012 Jun 29.

2.

Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study.

Soltani A, Reid DW, Sohal SS, Wood-Baker R, Weston S, Muller HK, Walters EH.

Respir Res. 2010 Jul 30;11:105. doi: 10.1186/1465-9921-11-105.

3.

Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease.

Soltani A, Muller HK, Sohal SS, Reid DW, Weston S, Wood-Baker R, Walters EH.

Histopathology. 2012 May;60(6):964-70. doi: 10.1111/j.1365-2559.2011.04147.x. Epub 2012 Feb 9.

4.

Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease.

Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH.

Respirology. 2010 Aug;15(6):930-8. doi: 10.1111/j.1440-1843.2010.01808.x. Epub 2010 Jul 12.

PMID:
20630030
5.

Transforming growth factor (TGF) β1 and Smad signalling pathways: A likely key to EMT-associated COPD pathogenesis.

Mahmood MQ, Reid D, Ward C, Muller HK, Knight DA, Sohal SS, Walters EH.

Respirology. 2017 Jan;22(1):133-140. doi: 10.1111/resp.12882. Epub 2016 Sep 11.

PMID:
27614607
6.

Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD.

Kokturk N, Tatlicioglu T, Memis L, Akyurek N, Akyol G.

J Asthma. 2003 Dec;40(8):887-93.

PMID:
14736088
7.

Polymeric immunoglobulin receptor down-regulation in chronic obstructive pulmonary disease. Persistence in the cultured epithelium and role of transforming growth factor-β.

Gohy ST, Detry BR, Lecocq M, Bouzin C, Weynand BA, Amatngalim GD, Sibille YM, Pilette C.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):509-21. doi: 10.1164/rccm.201311-1971OC.

PMID:
25078120
8.

Reticular basement membrane in asthma and COPD: similar thickness, yet different composition.

Liesker JJ, Ten Hacken NH, Zeinstra-Smith M, Rutgers SR, Postma DS, Timens W.

Int J Chron Obstruct Pulmon Dis. 2009;4:127-35. Epub 2009 Apr 15.

9.

Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.

Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, Byers T, Bunn PA Jr, Lewis MT, Franklin WA, Hirsch FR, Kittelson J.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2425-31.

10.

Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD).

Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A.

Am J Respir Crit Care Med. 2001 May;163(6):1476-83.

PMID:
11371421
11.

Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis.

Soltani A, Ewe YP, Lim ZS, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH.

Eur Respir J. 2012 Jun;39(6):1361-7. doi: 10.1183/09031936.00084411. Epub 2011 Oct 27.

12.

Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction.

Calabrese C, Bocchino V, Vatrella A, Marzo C, Guarino C, Mascitti S, Tranfa CM, Cazzola M, Micheli P, Caputi M, Marsico SA.

Respir Med. 2006 Aug;100(8):1415-22. Epub 2006 Feb 23.

13.

Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease.

de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH.

Am J Respir Crit Care Med. 1998 Dec;158(6):1951-7.

PMID:
9847291
14.

[The expression of transforming growth factor beta-1 in rat model of chronic obstructive pulmonary disease and the effects of early drugs intervention].

Wu DQ, Liu J, Lu XY, Shen HH.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Sep;33(5):427-32, 448. Chinese.

PMID:
15476327
15.

Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD.

Baraldo S, Bazzan E, Turato G, Calabrese F, Beghé B, Papi A, Maestrelli P, Fabbri LM, Zuin R, Saetta M.

Thorax. 2005 Dec;60(12):998-1002. Epub 2005 Oct 14.

16.

Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease.

Shukla SD, Sohal SS, Mahmood MQ, Reid D, Muller HK, Walters EH.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 13;9:853-61. doi: 10.2147/COPD.S67044. eCollection 2014.

17.

Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.

Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN.

COPD. 2006 Dec;3(4):179-87.

PMID:
17361498
18.

Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study.

Rogers AV, Adelroth E, Hattotuwa K, Dewar A, Jeffery PK.

Thorax. 2008 Feb;63(2):108-14. Epub 2007 Sep 17.

PMID:
17875567
19.
20.

Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke.

Milara J, Peiró T, Serrano A, Cortijo J.

Thorax. 2013 May;68(5):410-20. doi: 10.1136/thoraxjnl-2012-201761. Epub 2013 Jan 7.

PMID:
23299965

Supplemental Content

Support Center